1. Home
  2. CFFN vs NEO Comparison

CFFN vs NEO Comparison

Compare CFFN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$7.61

Market Cap

981.1M

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.40

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
NEO
Founded
1893
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.1M
1.0B
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
CFFN
NEO
Price
$7.61
$8.40
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$7.25
$13.38
AVG Volume (30 Days)
855.9K
2.2M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
N/A
EPS
0.32
N/A
Revenue
$16,300,000.00
N/A
Revenue This Year
$20.16
$10.63
Revenue Next Year
$6.62
$9.73
P/E Ratio
$23.53
N/A
Revenue Growth
6.54
N/A
52 Week Low
$5.51
$4.72
52 Week High
$7.97
$13.74

Technical Indicators

Market Signals
Indicator
CFFN
NEO
Relative Strength Index (RSI) 50.36 46.83
Support Level $7.47 $7.50
Resistance Level $7.85 $8.84
Average True Range (ATR) 0.16 0.55
MACD -0.04 -0.07
Stochastic Oscillator 39.08 10.44

Price Performance

Historical Comparison
CFFN
NEO

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: